Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Equity: 2016-2024

Historic Return on Equity for Sunshine Biopharma (SBFM) over the last 9 years, with Dec 2024 value amounting to -0.23%.

  • Sunshine Biopharma's Return on Equity fell 7.00% to -0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.24%, marking a year-over-year decrease of 7.00%. This contributed to the annual value of -0.23% for FY2024, which is 2.00% down from last year.
  • Sunshine Biopharma's Return on Equity amounted to -0.23% in FY2024, which was down 9.16% from -0.21% recorded in FY2023.
  • Sunshine Biopharma's Return on Equity's 5-year high stood at 33.47% during FY2021, with a 5-year trough of -2.45% in FY2022.
  • Over the past 3 years, Sunshine Biopharma's median Return on Equity value was -0.23% (recorded in 2024), while the average stood at -0.96%.
  • As far as peak fluctuations go, Sunshine Biopharma's Return on Equity surged by 3,017bps in 2021, and later slumped by 3,592bps in 2022.
  • Sunshine Biopharma's Return on Equity (Yearly) stood at 3.29% in 2020, then soared by 3,017bps to 33.47% in 2021, then tumbled by 3,592bps to -2.45% in 2022, then spiked by 224bps to -0.21% in 2023, then decreased by 2bps to -0.23% in 2024.